Press release
The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis
Roots Analysis is pleased to announce the publication of its recent study, titled, “Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms (Ophthalmic Drops, Emulsions, Gels, Injections, Lotions, Ointments, Suspensions, and Tablets / Capsules), 2020-2030.”
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html
The report features an extensive study of the contract services market for ophthalmic products and solutions. It features in-depth analyses, highlighting the capabilities of a diverse set of CMOs and CDMOs. Amongst other elements, the report includes:
A detailed review of the ophthalmic drugs contract manufacturing market landscape, featuring a list of over 240 CMOs and analysis based on a number of relevant parameters.
A competitiveness analysis of prominent contract manufacturers, featuring insightful pictorial summaries and representations.
Elaborate profiles of key players that offer a diverse range of capabilities for the contract development, manufacturing and packaging of ophthalmic drug products.
A detailed clinical trial analysis of completed, ongoing and planned studies of various ophthalmic drug products.
An estimate of the overall, annual capacity for manufacturing ophthalmic APIs and drug FDFs based on data reported by industry stakeholders in the public domain.
An informed estimate of the annual clinical and commercial demand for ophthalmic APIs and drug FDFs.
A discussion on affiliated trends, key drivers and challenges, under a comprehensive SWOT framework, including a Harvey ball analysis highlighting the relative effect of each SWOT parameter on the overall industry.
A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing contract manufacturing services to ophthalmic drug developers.
A discussion on the emerging trends and potential market drivers, which are likely to impact the evolution of the market in the coming years.
A detailed list of over 55 ophthalmic medical device contract manufacturers, along with information on a number of relevant parameters.
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Type of product
Ophthalmic API
Ophthalmic drug FDF
Type of FDF manufactured
Solid
Semi-solid
Liquid / suspension
Type of primary packaging
Ampoule / vial
Glass / plastic bottle
Ointment tube
Blister packing
Other forms
Scale of manufacturing
Clinical
Commercial
Company size
Small
Mid-sized
Large
Very large
Target disease indication
Age-related macular degeneration
Dry eye
Glaucoma
Other disease segments
Key geographical regions
North America (US, Canada and Mexico)
Europe (UK, Germany, France, Spain, Italy and rest of Europe)
Asia-Pacific (India, China, Japan, Australia and rest of Asia-Pacific)
Rest of the world
Key companies covered in the report
Akorn
Akums
Bal Pharma
Catalent
Cayman Chemical
Entod Pharmaceuticals
Farmigea
Glenmark Pharmaceuticals
Indiana Ophthalmics
Lomapharm
Medichem
Pillar5 Pharma
Recipharm
Salvat
Sterling Pharmaceutical Services
Sunways India
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/ophthalmic-drugs-cmo/294.html
Other Recent Offerings
1. China Biopharmaceutical Contract Manufacturing Market, 2020-2030
2. Pharmaceutical Continuous Manufacturing Market, 2020-2030
3. Peptide Therapeutics: Contract API Manufacturing Market, 2020-2030
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis here
News-ID: 2197338 • Views: …
More Releases from Roots Analysis
Respiratory syncytial virus infections are recognized among the prevalent respir …
Currently, several traditional techniques are available for treating these infections, although none of them have been competent enough to reduce the healthcare burden of RSV diseases. In order to address this, RSV vaccines emerged as a promising alternative, which provides active immunity against the RSV infections, thus protecting the vulnerable population. Further, by providing targeted immunity, these vaccines help reducing the severity of RSV infections and lower the hospitalization rates…
Rise in demand of glp-1 drugs for metabolic disorders.
In recent years, owing to its broader clinical potential in the treatment of obesity and type 2 diabetes, along with their proven efficacy in reducing cardiovascular risks, GLP-1 drugs market has garnered significant traction within the medical science domain.
Concurrently, the rising demand and escalating prevalence of metabolic disorder including type 2 diabetes and obesity are fueling the need for treatments capable of effectively managing these conditions. This trend is expected…
Carbon footprint management market is Set to Soar to USD 55.9 Billion by 2035
Carbon footprint refers to the measurement of greenhouse gas emissions, expressed in carbon dioxide equivalent. It is released into the atmosphere either directly or indirectly through various activities, processes, or products. These emissions originate from diverse sources, including energy consumption, manufacturing processes, transportation networks, and waste management strategies.
The global carbon footprint management market, valued at USD 12.2 billion in 2024, is expected to reach USD 13.5 billion in 2025…
Gene switches have garnered significant attention from drug developers owing to …
The global gene switch market size is estimated to grow from USD 795 million in 2025 to USD 2,478 million by 2035, representing a CAGR of 12.03% during the forecast period till 2035.
Driven by numerous developmental breakthroughs and encouraging study results demonstrating the vast potential of adoptive cell therapies (ACT), including CAR-T cell therapies, TCR therapies, TILs and natural killer cell therapies, in the treatment of various complex disorders, this…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
